SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or ...
Medical device company Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with benign prostatic hyperplasia (BPH) in the ZEST pilot ...
Round to Support PMA Submission of Minimally Invasive Treatment for Enlarged Prostate Symptoms SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company ...